Clinical trial
Efficacy of Two Different Dose Regimens of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Two Different Dose Regimens of Somatropin in Growth Hormone Deficient Adult Patients
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 1997
- Completion date
- December 31, 1998
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
growth hormone deficiency